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Background: Increased epicardial fat volume (EFV) is discussed to be an independent risk factor for coronary artery calcification (CAC). Both EFV 
and CAC are known to underlay mechanisms of systemic inflammation.
methods: We analyzed EFV and CAC from patients undergoing coronary computed tomography for the detection or for the rule out of coronary 
artery disease. Traditional risk factors were obtained. A broad range of systemic inflammation markers (eotaxin, G-CSF, GM-CSF, IFN-γ, interleukin (IL) 
6, IL 8, IP-10, MCP-1, MIP-1α, MIP-1α, TNF-α, and CRP) were analyzed. In a logistic regression model for binned inflammation markers we included 
the traditional cardiovascular risk factors, age, gender and obesity. Follow up data was obtained after 1.9 ± 0.5 years.
results: 391 patients (mean age 60 ± 10 years, 272 male gender) were enrolled for a baseline CT. Mean EFV was 116 ± 50 mL. Median CAC 
was 12 AU (IQR 0; 152). CAC and EFV showed a high significant correlation (p< 0.001). EFV and CAC were significantly associated with risk factors 
like age, male gender, diabetes mellitus, and hypertension. In multivariate analysis obesity had the highest odds ratio of 5.00 (p< 0.001; CI 95%) 
for predicting high EFV. Regarding biomarkers, CAC was significantly associated (negatively) with C-CSF and IL13. EFV was significantly correlated 
(positively) with the biomarkers IP-10 (p= 0.002) and MCP-1 (p= 0.037). IP-10 (values binned, >150 pg/mL) displayed as an independent predictor 
for high EFV with an odds ratio of 1.66 (p= 0.033). In the follow up group data from 77 patients could be obtained. EFV showed an annualized 
progression from 6 ml (IQR 3; 9) (p< 0.001), CAC from 6 AU (IQR 0;30) (p< 0.001). The progression of CAC was significantly correlated with the 
extent of EFV (p< 0.001) while there was no significant correlation between progression of EFV or CAC with the systemic inflammation markers.
conclusion: EFV and CAC themselves are significantly correlated as well as the progression of CAC with the amount of EFV. While each one, EFV 
and CAC, show significant correlations with systemic inflammation markers (CAC: C-CSF and IL 13; EFV: MCP-1 and IP-10), the biomarkers show no 
significant correlation with the progression of CAC and EFV.
